
Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are trading lower in Monday's after-hours session after the company reported financial results.
Ginkgo Bioworks said first-quarter revenue increased 282% year-over-year to $168 million, which beat the $105.68-million estimate, according to data from Benzinga Pro. The company said it added 11 new cell programs in the first quarter, representing 175% growth year-over-year.